Overview & Mechanism

Tirzepatide is a synthetic 39-amino acid peptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By simultaneously activating both incretin pathways, tirzepatide enhances glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, and influences central appetite regulation. It has become one of the most extensively investigated peptides in metabolic disease, obesity, and energy homeostasis research.

Key Research Focus Areas:

Dual Incretin Receptor Activation: Extensively investigated for its simultaneous activation of GIP and GLP-1 receptors, providing complementary metabolic signaling pathways.

Body Composition Research: Studied for its effects on body weight regulation, adipose tissue metabolism, and energy balance in preclinical and clinical research.

Glucose Homeostasis: Evaluated for improving glucose-dependent insulin secretion while reducing glucagon release and supporting glycemic regulation.

Cardiometabolic Health: Explored for its influence on insulin sensitivity, lipid metabolism, and broader cardiometabolic biomarkers in metabolic research.

Technical Profile & Validation

This lyophilized peptide is manufactured to an exceptional research standard exceeding 99% purity. Tirzepatide demonstrates outstanding molecular stability and receptor specificity, making it a preferred research compound for laboratory investigations involving incretin biology, metabolic regulation, obesity, and endocrine physiology.

Scientific Reference:
Tirzepatide: A Systematic Update
https://pubmed.ncbi.nlm.nih.gov/36498958/

Technical Specifications

⚠️ Important Reconstitution Notice Before initiation of the reconstitution protocol, ensure that both the lyophilized peptide vial and the bacteriostatic mixing water have stabilized at room temperature (20°C - 22°C). This step supports proper molecular dissolution and prevents potential destabilization of the micropeptide chain. Note: Bacteriostatic water is distributed separately.

Legal Disclaimer

All compounds and products featured on this platform are synthesized and distributed strictly for laboratory research, in vitro evaluation, and academic studies. These substances are under no circumstances intended, approved, or cleared for human or animal consumption, nor should they be classified as medical products, therapies, drugs, or food supplements.

By executing a purchase, the buyer explicitly assumes all associated biochemical risks and guarantees handling by qualified personnel within a controlled environment. The manufacturer, distributor, and seller maintain a policy of zero liability for any misuse, unauthorized administration, or unverified secondary outcomes. Finalizing your order constitutes full compliance with our academic research terms and conditions.